Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2025	Dec. 31, 2024
Fixed maturity available-for-sale securities, at fair value
Amortized Cost	$ 98,632	$ 97,415
Allowance for Credit Losses	97	46
Mortgage loans on real estate, net of allowance for credit losses
Fair value	$ 230	$ 232
Stockholders’ Equity
Preferred stock - authorized (in shares)	10,000,000	10,000,000
Preferred stock - issued (in shares)	40,000	40,000
Preferred stock - outstanding (in shares)	40,000	40,000
Common stock - authorized (in shares)	800,000,000	800,000,000
Common stock - issued (in shares)	189,920,627	170,380,646
Common stock - outstanding (in shares)	189,920,627	170,380,646
Series C Preferred Stock
Stockholders’ Equity
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000
Series D Preferred Stock
Stockholders’ Equity
Preferred stock - authorized (in shares)	20,000	20,000
Preferred stock - issued (in shares)	20,000	20,000
Preferred stock - outstanding (in shares)	20,000	20,000